Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 23, Issue 3, Pages 339-352Publisher
ADIS INT LTD
DOI: 10.1007/s40257-022-00674-3
Keywords
-
Categories
Ask authors/readers for more resources
Actinic keratosis is a chronic skin disease commonly found on sun-exposed areas. It may progress into skin cancer, highlighting the importance of treatment regardless of severity. Updates on long-term efficacy of current therapies and new agents are critical due to the aging population.
Actinic keratosis (AK) is a chronic skin disease in which clinical and subclinical cutaneous lesions coexist on sun-exposed areas such as the head and neck region and the extremities. The high prevalence of AK means the disease burden is substantial, especially in middle-aged and elderly populations. Evidence indicates that AK may progress into invasive cutaneous squamous cell carcinoma, so the European guidelines recommend treatment of any AK regardless of clinical severity. Given the aging population and therefore the increasing incidence of AK and cutaneous field carcinogenesis, further updates on the long-term efficacy of current therapies and new investigational agents are critical to guide treatment choice. Patients often have difficulty adequately applying topical treatments and coping with adverse local skin reactions, leading to less than optimum treatment adherence. The development of associated local skin symptoms and cosmetic outcomes for the area of interest are also relevant to the choice of an appropriate therapeutic strategy. Treatment is always individually tailored according to the characteristics of both patients and lesions. This review focuses on the therapeutic approaches to AK and illustrates the currently available home-based and physician-managed treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available